Our study confirms the pivotal role of IL-1β in SS and shows that the marked efficacy of anakinra on clinical symptoms is associated with a dramatic decrease of abnormal IL-1β, IL-6 and TNF-α production by LPS-stimulated PBMCs. The gene discussed is TNF; the disease is synovial sarcoma.